INTEC PHARMA LTD. Retained Earnings
INTEC PHARMA LTD. had Retained Earnings of -$207.78 million as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-05-17
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$207.78M.
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$203.55M.
- 2020-09-30: Retained Earnings (Accumulated Deficit) -$199.98M.
- 2020-06-30: Retained Earnings (Accumulated Deficit) -$196.24M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-03-31 | -$207.78M 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$203.55M 10-Q · filed 2021-05-17 |
| 2020-09-30 | -$199.98M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$196.24M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$193.29M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$189.42M 10-K · filed 2021-03-16 |
| 2019-09-30 | -$182.87M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$162.49M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$152.48M 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$141.82M 10-K · filed 2020-03-13 |
| 2017-12-31 | -$98.28M 10-K · filed 2019-02-27 |